Combining the Power of ctDNA and Real-World Data to Optimize Clinical Development

Time: 2:45 pm
day: Track A - Day 1 am

Details:

• How a circulating tumor DNA (ctDNA) assay can be used in clinical trials to (1) stratify and enrich for patients most likely to benefit from additional therapy and (2) monitor therapy response for early prediction of efficacy
• Latest case studies combining ctDNA and real-world data to optimize and accelerate clinical development and maximize likelihood of clinical trial success

Speakers: